- Medistore
- Vaccinations
- Adults
- HPV vaccination package (3 doses of vaccine)
HPV vaccination package (3 doses of vaccine)
HPV vaccination package (3-dose schedule) for children aged 15 years and older and adults.
Medicover
Name: A to Z

-40% with MediClub!
4.3
(4 opinions)
The price includes all fees
Lowest price from 30 days before discounting PLN 1,449.00


Key Information About the Vaccination
|
Vaccination |
HPV vaccination – 9-valent vaccine (3-dose package) |
|
Who is it for? |
Children over 9 years of age, adolescents and adults |
|
Number of doses |
3 doses |
|
When is the best time to get vaccinated? |
Most effective before the onset of sexual activity |
|
Duration of protection |
When administered at a young age, it may provide protection against HPV for up to 50 years |
|
Is a referral required? |
No |
|
Qualification visit required |
A medical qualification visit is required before each vaccine dose. The package does not include qualification visits. |
What is the HPV vaccination for?
HPV vaccination is a form of prevention against cancers and lesions caused by the human papillomavirus (HPV).
Cervical cancer is one of the most common cancers in women. A key factor in its development is HPV infection, as well as factors such as smoking, unhealthy lifestyle, and multiple natural childbirths. There are over 100 types of HPV – some cause mild lesions such as skin warts, while others lead to the development of malignant cancers.
Infection with certain HPV types may lead to the development of:
- cervical cancer,
- genital warts (condylomata acuminata),
- laryngeal cancer,
- anal cancer,
- oral cancer,
- throat cancer,
- vaginal cancer,
- vulvar cancer,
- penile cancer.
Nearly all cases of cervical cancer are caused by just a few HPV subtypes – mainly types 16 and 18, as well as 31, 33, and 45. These are high oncogenic risk viruses.
HPV types 6 and 11, which have low oncogenic potential, are the main cause of genital warts.
HPV infection is transmitted primarily through sexual contact, often at an early stage of sexual activity. It is estimated that 50–80% of sexually active individuals have had or will have contact with HPV during their lifetime. Many people are unaware they are carriers, as the infection often has no symptoms.
Cervical cancer is a disease that can be effectively prevented through vaccination and regular cervical screening (Pap tests). Early detection allows for complete recovery.
How does the vaccine work?
HPV vaccination stimulates the body to produce immunity, helping prevent infection with specific types of the virus. As a result, the risk of developing cervical cancer and other HPV-related cancers is significantly reduced.
The 9-valent HPV vaccine protects against types 6, 11, 16, 18, 31, 33, 45, 52, and 58. Seven of these are responsible for nearly 90% of cervical cancer cases. The vaccine also prevents genital warts and cancers and precancerous lesions of the vulva, vagina, cervix, and anus caused by HPV.
The vaccine:
- helps the immune system recognize the pathogen more quickly,
- more effectively limits the development of infection,
- reduces the risk of cancer-related complications.
How many doses are included in the vaccination schedule?
The vaccination schedule depends on the age of the vaccinated person:
- up to 14 years of age – 2 doses provide full immunization,
- from 15 years of age and in adults – a 3-dose schedule applies.
In the 3-dose schedule:
- the second dose should be administered at least one month after the first dose,
- the third dose at least 3 months after the second dose,
- all 3 doses should be administered within 1 year.
The entire vaccination course should be completed with the same vaccine. If the 2- or 4-valent vaccine is unavailable, the schedule may be completed with the 9-valent vaccine. If subsequent doses are administered later than recommended, the course should be completed as soon as possible – there is no need to restart the vaccination series or repeat doses.
When is it worth getting the HPV vaccine?
The vaccination is most effective when administered before the onset of sexual activity.
It is recommended by the Minister of Health under the National Immunization Program and endorsed by the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and numerous scientific organizations in pediatrics, gynecology, and oncology.
Who is the HPV vaccination for?
The vaccine is intended for:
- children over 9 years of age,
- adolescents,
- adults.
HPV can infect both women and men.
HPV vaccination in the context of abnormal Pap smear results
If the Pap smear result is abnormal (e.g., ASC-US, LSIL, HSIL) and suggests HPV-related changes, the indications for vaccination may vary depending on the patient’s condition and the type of abnormalities detected.
In cases of abnormal cytology results or confirmed HPV infection:
- vaccination with the 9-valent vaccine should be considered,
- vaccination does not eliminate an existing infection but supports immunity and may aid in the self-resolution of existing lesions,
- it provides protection against other HPV types covered by the vaccine.
Studies indicate that vaccinating individuals with abnormal cytology results may help prevent future infections with other HPV types and reduce the risk of further lesion progression, including cancer. However, vaccination does not replace treatment of already detected lesions or regular medical monitoring.
How to prepare for HPV vaccination?
No special preparation is required before vaccination.
*Preparation requirements may vary depending on the medical facility.
What are the contraindications to HPV vaccination?
The vaccine should not be administered in the following cases:
- allergy to the active substance or any of the excipients,
- occurrence of an allergic reaction after a previous dose,
- age below 9 years.
In the case of an acute, severe infection accompanied by a high fever, vaccination should be postponed to a later date. Mild infections, such as a common cold or low-grade fever, are not contraindications to vaccination.
What does the vaccination visit look like?
After purchasing the 3-dose package, a medical qualification visit must be scheduled before each vaccine dose. The vaccination is administered immediately after the qualification visit. The package does not include qualification visits. Patients with Medicover healthcare coverage may schedule the qualification visit under their healthcare plan, while patients without such coverage must purchase the qualification visit separately.
If the doctor does not qualify the patient for vaccination, a new qualification visit must be scheduled at the time indicated by the doctor. The subsequent visit is additionally paid (unless it is included in the patient’s current healthcare subscription plan).
Important
The product does not include qualification visits for vaccination. Patients whose healthcare plan does not cover qualification visits must purchase them separately.
You can complete the vaccination within 3 months from the date indicated in the order confirmation.
Frequently Asked Questions (FAQ)
Does HPV vaccination replace Pap smear screening?
No. Vaccination does not replace regular cervical screening (Pap smear) or other preventive methods against HPV infection and sexually transmitted diseases.
Should women over 25 undergo additional tests?
Women over 25 years of age are recommended to undergo liquid-based cytology (LBC) together with HPV genotyping.
Can the vaccine be administered together with other vaccines?
The vaccine may be administered at the same time as other vaccinations if the doctor considers it safe during the qualification visit.
Do I need to restart the vaccination cycle if the interval between doses was too long?
No. If subsequent doses were administered later than recommended, the vaccination course should be completed as soon as possible. There is no need to restart the entire cycle or repeat doses.
Related medical consultations
